Explore. Learn. Join the conversation.

Working Group on New TB Drugs

Stop TB Partnership

Targets

« Return to Targets Overview

Contact Info

Pablo Bifani pablo.bifani@novartis.com 67223524

Aerobic Mtb whole cell screens

Last Updated: 2-Nov-2011

Target Description

EC number
Genbank accession
Rv number


Research Investigator(s)
Novartis Institue For Tropical Diseases (NITD), Singapore and Genomics Institute of the Novartis Research Foundation (GNF), USA

Has the target been validated? How?

Validated by:
Chemical
PubMed References

Reagent Description

Recombinant Protein Name / Gene ID Soluble? Truncated? Mutant? PubMed References

Assay Description

Assay Name Readout Format PubMed References
Cell-based

Compounds for Screening or Lead Optimization

Library Name/Indentifier Total # of Compounds Screened HTS Cut Off (ie. 40 um) # of Hits # of Leads PubMed References
Novartis archive 2.2 Million 5uM 4,800 4 +++

Hits or Leads

Counter-Screen Assay (Target or Cell Based)

Cytotox assay

Narrative Description

SAR, Hit to lead and Target deconvolution is in progress